BioAdaptives, Inc. (BDPT) est une société cotée en bourse dans le Consommation Défensive secteur, opérant dans le Packaged Foods secteur d'activité. Le siège social de l'entreprise est situé à Las Vegas, NV, United States. Le PDG actuel est James E. Keener.
BDPT a date d'introduction en bourse 2014-07-09, 1 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $109.44K.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
